CHMP recommends empagliflozin / metformin hydrochloride for approval in the EU for the treatment of Type 2 Diabetes
30 March 2015 | By Victoria White
BI and Lilly announce they have received a positive opinion from CHMP, recommending empagliflozin/metformin hydrochloride for the treatment type 2 diabetes...